Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Published:2016-12 Issue:6 Volume:151 Page:1113-1121
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Lembo Anthony,Pimentel Mark,Rao Satish S.,Schoenfeld Philip,Cash Brooks,Weinstock Leonard B.,Paterson Craig,Bortey Enoch,Forbes William P.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Functional bowel disorders;Longstreth;Gastroenterology,2006

2. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis;Ford;Am J Gastroenterol,2014

3. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation;Ford;Am J Gastroenterol,2014

4. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis;Ford;Am J Gastroenterol,2014

5. Eluxadoline for irritable bowel syndrome with diarrhea;Lembo;N Engl J Med,2016

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irritable Bowel Syndrome: Current Landscape of Diagnostic Guidelines and Therapeutic Strategies;Gastroenterology Insights;2024-09-09

2. Bewährtes und Neues in der Arzneitherapie des Reizdarmsyndroms;Die Innere Medizin;2024-08-09

3. Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial;Scientific Reports;2024-08-05

4. Algorithms or biomarkers in patients with lower DGBI?;Neurogastroenterology & Motility;2024-06-27

5. Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea;Heliyon;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3